| Tag | Content |
|---|
EnhancerAtlas ID | HS194-02939 |
Organism | Homo sapiens |
Tissue/cell | Urothelial_cell |
Coordinate | chr2:38373480-38374610 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr2:38374207-38374222 | GTCTGACTCAGCAGT | + | 6.13 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09578 | chr2:38370490-38377561 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I038145 | chr2 | 38372277 | 38377046 |
|
Enhancer Sequence | TTCCCCATTC TCAGTAGAAA AACAAAATGG TCATTAATTT ATTTTGACAT GCAAACTCAG 60
CTGAACATTT TTTGGTGATT CAACCCCACA GATGTAAAGT GAAAGAGTGC CAGAAAAGCA 120
AGTGAGAGCC ATGAGATTAC CACAAGTCTG TGAGCACATT TTTTTCAAGG CTTACAGAAT 180
CCCAAAGCTT GCCCTTGCTT CAGGAAAAAG AACTGGTTGA CACCTGAGAG GTTTTAAGCC 240
ACAAGAAGCT GAGGCCCGTT GTGAGGAGGG CAGGGACAGT GGGGCCAGGC CACACGCGAC 300
GCGTCACCCA CCTCCTGCCT CACCTCCCCC CACTGAGATG TCTGCTGGGT GGGAGGAGGC 360
TTATTGCCAG AGAACAGTCT GGTGTTTTCT GTTCCTGCTT CAGGAAGTCC CCCTTCTCCC 420
GCCACCCCCG CAGCTCCTCA GCCTGGAAAC AACTTTTAGA GAGGAGAAGG GAAGCAAAGC 480
TTTCAAAAGC AGATACCTGT GGGGTTTGAA GGGAGGTGCC CCTTGTTCAA GTATTTCTCC 540
CCCAAAATTG AAAGGACACT TCAGATTCAT TCATTTTAGT TTTGATGTAT CTTCAGTAAT 600
TAAGAAGCCA CTAAGAAAAC TGACCCTGGG AAGGCAAATT CCTGAAGCTG AGTCAGATAC 660
AGCCAGCTCT TACCATACCA TCTGACCCTC AGTTCCCTCT GACCTCATCT CTTCCCACCT 720
CCTCTCTGTC TGACTCAGCA GTGAGGCCAC ACAGGCCTCC CTGCTGATTC GAGAATGGCT 780
CCCACCTGAG GCCTTGGGCC CCCCTTGTTT TCGCCCCCAC ATACCCATCT GGCTTCCCCT 840
TCACTGCTTC CAAGGCTCTC CTCAGAGAGC ATCCTGTCAG ACCAGTCTTT CCTGGACATG 900
CTGAGTGTAC CTTTCCCCTA TTTCATTTTC CTTCGTGGCA CCTTTTACCA CCTGATATGT 960
TCAATGGCTC TATGTTTGTT TGTAGTAAGT CTCGCCTGAC TAGAATATAA GACCCATGGG 1020
AGAAGAGACT TTCTGCTCTA CCCTTGGCAC ATACCGGGTG CTCAAAAAAT ATTCAAGTGC 1080
TCGCTTCGGC AGTACATGTA CTAAAACTGG AACAATACAG AGAACATTAG 1130
|
